Alcon Price to Free Cash Flow Ratio 2019-2022 | ALC

Historical price to free cash flow ratio values for Alcon (ALC) since 2019. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Alcon Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2023-01-27 74.80 68.19
2022-09-30 58.18 $1.10 53.04
2022-06-30 69.89 $1.13 61.86
2022-03-31 79.33 $1.10 71.82
2021-12-31 87.12 $1.31 66.64
2021-09-30 80.47 $1.65 48.74
2021-06-30 70.26 $1.59 44.21
2021-03-31 70.18 $0.06 1143.00
2020-12-31 65.98 $0.18 360.35
2020-09-30 56.95 $0.04 1406.17
2020-06-30 57.32 $-0.10 0.00
2019-12-31 56.57 $0.75 75.26
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $36.722B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.442B 23.68
Edwards Lifesciences (EW) United States $48.354B 33.28
STERIS (STE) Ireland $20.456B 25.46
Teleflex (TFX) United States $11.305B 18.34
Fresenius Medical Care AG KGaA (FMS) Germany $10.584B 10.62
Penumbra (PEN) United States $9.289B 2223.46
Globus Medical (GMED) United States $7.506B 38.16
Integer Holdings (ITGR) United States $2.380B 19.11
Glaukos (GKOS) United States $2.298B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.402B 19.97
Paragon 28 (FNA) United States $1.303B 0.00
Nevro (NVRO) United States $1.291B 0.00
Artivion (AORT) United States $0.505B 0.00